- Filed
- May 15, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 15, 2026 | 113.32M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 112.5M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 104.73M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$982.05K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$428.1K |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $1.28M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $2.11M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $20.38M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $21.46M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $4.01M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $3.7M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $85.86M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $85.45M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $2.3M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $2.76M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $121.97M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $123.24M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.02 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.05 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.02 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.05 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $464.8K |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $439.91K |
| Net Income | Q1 2026 · Mar 31, 2026 | −$1.83M |
| Net Income | Q1 2026 · Mar 31, 2025 | $5.1M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$1.8M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$591.41K |
| Revenue | Q1 2026 · Mar 31, 2026 | $915.38K |